Results 251 to 260 of about 63,047 (307)

Putative Clonal Evolution in a PHF6‐Mutant T/NK‐Cell Lymphoproliferative Disorder With Selective Loss of a STAT5B‐Mutant Subclone

open access: yes
eJHaem, Volume 7, Issue 3, June 2026.
Mark Anthony Turingan   +4 more
wiley   +1 more source

Tacrolimus Concentration/Dose Ratio in Hematopoietic Cell Transplantation Recipients: An Exploratory Study of Metabolizer Phenotyping and Clinical Outcomes

open access: yesClinical and Translational Science, Volume 19, Issue 6, June 2026.
ABSTRACT Tacrolimus pharmacokinetics shows wide interindividual variability after allogeneic hematopoietic cell transplantation (HCT), potentially influencing both effectiveness and toxicity. The concentration‐to‐dose (C/D) ratio has been proposed as a simple surrogate marker of tacrolimus metabolism, enabling patient stratification into fast or slow ...
Luiz Carlos da Costa‐Junior   +8 more
wiley   +1 more source

Secondary neoplasms in survivors of pediatric acute lymphoblastic leukemia and lymphoblastic lymphoma: a single-center, retrospective study. [PDF]

open access: yesFront Pediatr
Ushida E   +12 more
europepmc   +1 more source

T lymphoblastic leukemia / lymphoblastic lymphoma

open access: yesJournal of The Showa Medical Association, 2011
openaire   +1 more source

HAT‐PCR is non‐inferior to NGS when quantifying measurable residual disease for myeloma

open access: yes
British Journal of Haematology, Volume 208, Issue 6, Page 2256-2259, June 2026.
Elizabeth Hughes   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy